Brief: LAVA Therapeutics Q4 Basic EPS USD -0.14
28/03/2025 11:49
March 28 (Reuters) - LAVA Therapeutics NV LVTX.O: LAVA THERAPEUTICS Q4 BASIC EPS USD -0.14 LAVA THERAPEUTICS Q4 NET INCOME USD -3.874 MILLION LAVA THERAPEUTICS Q4 PRETAX PROFIT USD -3.495 MILLION LAVA THERAPEUTICS Q4 OPERATING INCOME USD -6.922 MILLION Source text: ID:nGNX9l3GDr Further company coverage: LVTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on LAVA Therapeutics NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:29 PM
Brief: Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM